000			02098 a2200613 4500
005			20250515070938.0
264		0	_c20080114
008			200801s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/ard.2007.071464 _2doi
040			_aNLM _beng _cNLM
100	1		_aVonk, M C
245	0	0	_aLong-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cJan 2008
300			_a98-104 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGranulocyte Colony-Stimulating Factor _xtherapeutic use
650	0	4	_aHematopoietic Stem Cell Mobilization _xmethods
650	0	4	_aHematopoietic Stem Cell Transplantation _xmethods
650	0	4	_aHumans
650	0	4	_aLinear Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMorbidity
650	0	4	_aMyeloablative Agonists _xtherapeutic use
650	0	4	_aRecombinant Proteins
650	0	4	_aScleroderma, Systemic _xmortality
650	0	4	_aSurvival Rate
650	0	4	_aTransplantation Conditioning _xmethods
650	0	4	_aTransplantation, Autologous
700	1		_aMarjanovic, Z
700	1		_avan den Hoogen, F H J
700	1		_aZohar, S
700	1		_aSchattenberg, A V M B
700	1		_aFibbe, W E
700	1		_aLarghero, J
700	1		_aGluckman, E
700	1		_aPreijers, F W M B
700	1		_avan Dijk, A P J
700	1		_aBax, J J
700	1		_aRoblot, P
700	1		_avan Riel, P L C M
700	1		_avan Laar, J M
700	1		_aFarge, D
773	0		_tAnnals of the rheumatic diseases _gvol. 67 _gno. 1 _gp. 98-104
856	4	0	_uhttps://doi.org/10.1136/ard.2007.071464 _zAvailable from publisher's website
999			_c17069881 _d17069881